Skip to main content
GWGovwatch
CongressBillsCommitteesPresidentMoneyPulseMisconductElectionsMap
Donate

Weekly accountability digest

One email a week with new votes, moving bills, and misconduct updates. No spam.

GW

Govwatch. Public data about Congress, in one place, in plain English.

Built with public data. Not affiliated with the U.S. government.

Explore

  • Officials
  • Legislation
  • Committees
  • Congress Pulse
  • Trending Topics
  • Bipartisan Leaderboard
  • Weekly Digest
  • Misconduct
  • Predictions

Learn

  • How Congress Works
  • How a Bill Becomes Law
  • Campaign Finance 101
  • Glossary

Tools

  • My Representatives
  • Compare Members
  • Bill Watchlist
  • Search
  • District Map
  • Follow the Money
  • Watch Live

Site

  • About
  • Contact
  • Corrections
  • Privacy Policy
  • Terms of Service

Data Sources

Congress.gov API v3
Bills, members, votes
GovInfo API
Floor speeches, reports, bill text
Federal Election Commission (FEC)
Campaign finance
VoteView (UCLA)
Ideology scores (DW-NOMINATE)
GovTrack.us
Misconduct data (CC0)
U.S. Census Bureau
District demographics

Data Last Updated

Bills & Votes: 1 hour ago
Support This Project

This site is free. Donations help cover hosting, API fees, and keeping the data fresh.

All data is sourced from official government APIs and public records. This site is for informational purposes only.

© 2026 Govwatch

HR8192Referred to Committee

Nitazene Response Act

Share:
Introduced
In Committee
3
Passed One Chamber
4
Passed Both
5
Signed into Law
119th
Congress
2026-04-02
Introduced
0
Cosponsors
HR
ⓘ
Type

Sponsor

David J. Taylor
David J. Taylor
Republican · OH · Representative
Votes with party: 98.0% (608 recorded votes)

Full profile: /officials/T000490

Source: Congress.gov · FEC

Cosponsors (0)

Members who have signed on to support this bill since introduction. Source: Congress.gov.

No cosponsors on record. Bills can pass without cosponsors — this often means the sponsor introduced the bill alone, either because it's a messaging bill, a chairman's mark, or simply early in the legislative cycle.

Latest Action

The most recent step in the bill's legislative path. Committee Activity below shows referrals and reports; the full action-by-action history including floor proceedings lives at Congress.gov →

Referred to the House Committee on Energy and Commerce.

2026-04-02

Source: Congress.gov

Committee Activity

Currently in

  • House Committee on Energy and CommerceReferred To · 2026-04-02

Previously

  • Energy and Commerce CommitteeReferred To · 2026-04-02

Plain-English Summary

This bill would address the growing problem of nitazene, a dangerous synthetic opioid that has been appearing in illegal drug supplies across the country. The legislation likely aims to increase law enforcement tools, public health responses, and potentially penalties related to nitazene production and distribution to help combat this emerging drug threat. The bill would affect drug enforcement agencies, public health officials, and communities struggling with opioid addiction.

AI-assisted summary generated from the official bill metadata (title, subjects, actions) sourced from Congress.gov. Cached and reviewed. Always verify against the official text linked below.

Subjects

Crime and Law Enforcement

Full Bill Text

Verbatim text published on Congress.gov via GovInfo. Use Cmd+F / Ctrl+F to search within this excerpt.

[Congressional Bills 119th Congress] [From the U.S. Government Publishing Office] [H.R. 8192 Introduced in House (IH)] <DOC> 119th CONGRESS 2d Session H. R. 8192 To direct the Secretary of Health and Human Services to issue guidelines for the purpose of addressing the problem of nitazene overdoses, and for other purposes. _______________________________________________________________________ IN THE HOUSE OF REPRESENTATIVES April 2, 2026 Mr. Taylor introduced the following bill; which was referred to the Committee on Energy and Commerce _______________________________________________________________________ A BILL To direct the Secretary of Health and Human Services to issue guidelines for the purpose of addressing the problem of nitazene overdoses, and for other purposes. Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled, SECTION 1. SHORT TITLE. This Act may be cited as the ``Nitazene Response Act''. SEC. 2. ASSISTANCE IN RESPONDING TO NITAZENE OVERDOSES. (a) Guidelines.-- (1) In general.--The Secretary of Health and Human Services (in this section referred to as the ``Secretary'') shall issue updated, evidence-based clinical guidelines (in this section referred to as the ``guidelines'') for responding to nitazene overdoses. (2) Contents.--The guidelines shall contain-- (A) a description of best practices for responding to potential nitazene overdoses, including protocols for administering naloxone; (B) guidance for emergency departments and hospitals in responding to nitazene overdoses; (C) guidance for rural and volunteer emergency medical services systems in responding to nitazene overdoses; and (D) such other information as the Secretary determines appropriate. (3) Publication.--Not later than 180 days after the date of enactment of this Act, the Secretary shall publish the guidelines on the public internet website of the Department of Health and Human Services. (b) Report to Congress.--Not later than one year after the date of enactment of this Act, the Secretary shall submit to Congress a report containing the guidelines and a description of how the guidelines will assist in addressing the problem of nitazene overdoses. (c) Definitions.--In this section: (1) Nitazene.-- (A) In general.--The term ``nitazene'' means benzimidazole-opioids, including any substance (including its salts, isomers, and salts of isomers) that has a chemical structure that is substantially similar to that of etonitazene or isotonitazene, including-- (i) a benzimidazole core substituted at the 2-position with a benzyl or substituted benzyl group; (ii) a basic nitrogen-containing side chain at the 1-position; and (iii) exhibits agonist activity at the mu- opioid receptor. (B) Included substances.--The term ``nitazene'' includes, at a minimum, the following: etonitazene, clonitazene, metonitazene, isotonitazene, protonitazene, butonitazene, etodesnitazene, flunitazene, N-pyrrolidino etonitazene, N-desethyl isotonitazene, and N-piperidinyl etonitazene. (2) Nitazene overdose.--The term ``nitazene overdose'' means an overdose involving nitazene or any other ultra-potent synthetic opioid. <all>
Open clean-text viewRead on Congress.gov →

Related legislation

Bills by the same sponsor or covering overlapping subjects.

  • HRES1429Expressing support for continued efforts to safeguard the supplemental nutrition assistance program under the Food and Nutrition Act of 2008 from fraud, waste, and abuse for the Nation's most vulnerable.
    Referred to Committee · 2026-07-14
  • HR7809To designate the facility of the United States Postal Service located at 201 East Grant Avenue in Georgetown, Ohio, as the "Ulysses S. Grant Post Office Building".
    Passed House · 2026-07-14
  • HRES1349Expressing support for the designation of the week of May 31 through June 6, 2026, as "Our Roads, Our Safety Week".
    Referred to Committee · 2026-06-08
  • HR8944Housing Regulatory Clarity Act of 2026
    Referred to Committee · 2026-05-20